Back to search
FDAFDA · Food and drugs·Recall number D-498-2013

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Published June 5, 2013 · Recall initiated: April 9, 2013

Summary

FDA records drug Class III recall D-498-2013, published June 5, 2013 and initiated April 9, 2013. Recalling firm: Aurobindo Pharma USA Inc; Status: Terminated; Reported quantity: 1776 bottles; Lot: Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

What to do

Voluntary: Firm initiated · Letter

Get an email if LISINOPRIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LISINOPRIL
Manufacturer
Aurobindo Pharma USA Inc
Distributor
Nationwide
UPC
0365862037015
Lot
Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India recalled?

Yes. FDA published recall D-498-2013 on June 5, 2013. Reported hazard: Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LISINOPRIL. UPC: 0365862037015.